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Abstract
Disruption of calcium homeostasis, inhibition of protein glycosylation, and reduction of disulfide bonds provoke
accumulation of unfolded protein in the endoplasmic reticulum (ER), and are therefore a type of ‘ER stress’. Normal cells
respond to ER stress by increasing transcription of genes encoding ER-resident chaperones such as GRP78/BiP, GRP94 and
protein disulfide isomerase to facilitate protein folding. This induction system is termed the unfolded protein response.
Familial Alzheimer’s disease-linked presenilin-1 (PS1) mutation downregulates the unfolded protein response and leads to
vulnerability to ER stress. The mechanisms by which mutant PS1 affects the ER stress response are attributed to the
inhibited activation of ER stress transducers such as IRE1, PERK and ATF6. ß 2001 Elsevier Science B.V. All rights
reserved.
Keywords: Unfolded protein response; Endoplasmic reticulum stress; Alzheimer disease; Presenilin; Amyloid-L peptide; GRP78/BiP
1. Introduction
Approximately one-third of newly synthesized pro-
teins are transported to the lumen of the endoplasmic
reticulum (ER). Posttranslational modi¢cations of
the proteins such as folding and oligomerization,
which are destined for distal compartments of the
secretory pathway, occur in the ER. Alterations
in homeostasis after various cellular stresses, which
prevent protein folding and cause accumulation of
misfolding or malfolding proteins in the ER, have
the potential to induce cellular damage [1]. Eukary-
otic cells can adapt for survival to deal with an ac-
cumulation of unfolded proteins in the ER. Their
response includes the transcriptional induction,
translational attenuation, and degradation of un-
folded proteins. In contrast, excessive and/or long-
term stress in the ER results in apoptosis. Recent
evidence indicates that ER stresses are associated
with genetic or neuronal degenerative diseases [2,3].
In this review, we focus on the recent progress in
studies on the unfolded protein response (UPR),
and its association with onset of familial Alzheimer’s
disease (FAD).
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2. ER stress and the cellular response
The ER is susceptible to various cellular stresses
that provoke the accumulation of unfolded proteins
in the ER, and these therefore are types of ‘ER
stress’. These stresses include calcium depletion
from the ER lumen, inhibition of asparagine (N)-
linked glycosylation, reduction of disul¢de bonds,
expression of mutant proteins, ischemic insults, etc.
[1,4,5]. Excessive or long-termed stresses in the ER
result in apoptotic cell death involving nuclear frag-
mentation, chromatin condensation, and shrinkage
of cell bodies (Fig. 1). Prior to apoptotic changes,
the lumen of the ER is enlarged, and ribosomes are
dissociated from the membrane of the ER (Fig. 2). In
lysates from the cells stimulated by various ER stres-
sors, cytochrome c is released from mitochondria to
cytosol and cleaved fragments of caspase-3 are grad-
ually accumulated, indicating biochemically that the
type of the cell death is apoptosis. Indeed, the apo-
ptosis induced by ER stress is delayed by treatment
with inhibitors of caspase-3 (J. Hitomi and K. Imai-
zumi, unpublished observations).
Normal cells respond to ER stress by increasing
transcription of genes encoding ER-resident chaper-
ones such as GRP78/BiP, GRP94 and protein disul-
¢de isomerase (PDI) to facilitate protein folding
[1,6,7]. This induction system is termed the UPR.
One of the best-characterized examples of ER-resi-
dent chaperones is the immunoglobulin binding pro-
tein BiP, which is known to prevent the secretion of
incompletely assembled immunoglobulins [8]. Inde-
pendently, BiP has been identi¢ed as a member of
a protein family that is induced upon conditions of
glucose deprivation [9]. Thus, since the expressions of
this family of proteins are induced by deprivation of
glucose, they are named glucose-regulated proteins
or GRPs. These proteins do not actively catalyze
protein folding, but rather maintain proteins in a
folding-competent state. Inhibition of GRP78/BiP
mRNA induction increases cell death in response to
calcium release from the ER, oxidative stress, hyp-
oxia and T-cell-mediated cytotoxicity [10^12], indi-
cating that the transcriptional induction of GRP78/
BiP is signi¢cant to protect against cell death caused
by various ER stresses.
3. ER stress transducers
The mechanisms of transcriptional induction of
ER-resident chaperones are well characterized in
the budding yeast Saccharomyces cerevisiae because
of the ease with which genetic experiments can be
conducted in this system. Some of the target genes
of the UPR share a common upstream activating
sequence in their promoters, the unfolded protein
response element (UPRE), that directs their tran-
scription upon induction of the UPR pathway. Anal-
ysis of KAR2 (the S. cerevisiae homologue of mam-
malian GRP78/BiP) promoter demonstrated that the
yeast 22 bp UPRE was su⁄cient for induction of ER
chaperones in response to ER stress [13,14]. A tran-
scription factor named Hac1p has been identi¢ed,
Fig. 1. Hoechst 33258 staining. Human neuroblastoma SK-N-SH cells were treated with 1 Wg/ml tunicamycin for 30 h (right panel,
Tunicamycin), or not treated (left panel, Control). Cells that were treated with tunicamycin show chromatin condensation and frag-
mentation (white arrow).
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which contains the basic leucine zipper (bZIP) do-
main and binds to the UPRE during ER stress [15^
17]. One form of Hac1p, Hac1pu (u for uninduced),
is synthesized constitutively. However, upon induc-
tion of the UPR, the HAC1 mRNA is spliced at a
non-consensus splice site to generate an alternative
protein product, Hac1pi (i for induced). Expression
of Hac1pi constitutively activates the UPR, but the
products encoded by unspliced Hac1pu are degraded
rapidly, and do not activate the UPR. The molecule
that processes HAC1 mRNA has been demonstrated
to be Ire1p (for inositol requiring and ER to nucleus
signaling) [18,19]. Ire1p is a type I transmembrane
protein whose N-terminal domain is located in the
ER lumen, and whose C-terminal domain is in
cytoplasm or nucleoplasm (Fig. 3). The C-terminal
domain contains serine/threonine-speci¢c protein ki-
nase and the RNase L domain, which has the poten-
tial to cleave HAC1 mRNA and generate Hac1pi
(Fig. 4).
Mammalian homologues of yeast Ire1p, IRE1K
and IRE1L have been identi¢ed in both human and
mice [20,21]. IRE1K is expressed ubiquitously, but
the expression of IRE1L is limited to cells of the
gut. Overexpression of IRE1K and L activates the
UPR, whereas the overexpression of IRE1 mutant
forms containing the luminal and transmembrane
domains but lacking the cytosolic domains downre-
gulated the UPR, supporting the concept that both
the kinase and RNase L domains in cytoplasmic re-
gions of IRE1s are essential for activation of the
UPR. It has been demonstrated that IRE1K cleaves
Fig. 2. Electron microscopic examination of apoptotic cells. Time courses of morphological changes of apoptotic SK-N-SH cells after
treatment with 1 Wg/ml tunicamycin for the indicated times. Apoptotic cells show the swelling of ER lumen (arrows) and dissociation
of ribosome from ER membranes before chromatin condensation and fragmentation (10 and 20 h after treatment with tunicamycin),
although the structures of the ER at 0 and 5 h after treatment are intact (arrows). (Right panel) Nuclear fragmentation of cells
treated for 30 h.
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yeast HAC1 precursor mRNA at the same sites that
yeast Ire1p does; however, the mammalian homo-
logue of yeast HAC1 has not been identi¢ed. Thus,
it is presently understood that signaling of the UPR
in mammalian cells is more diverse than in yeast
because additional pathways are activated that re-
spond to ER stress.
Recently, two elements which share a common 19
nucleotide sequence motif (CCAAT(N)9CCACG)
with a GC-rich 9 bp spacer in the GRP78/BiP pro-
moter region were reported to be implicated in in-
duction of GRP78/BiP, GRP94 and calreticulin in
response to ER stress [22,23]. This element has
been termed the ER stress-response element
(ERSE). Using a yeast one hybrid screening with
ERSE, the bZIP protein ATF6 was identi¢ed as a
candidate transcription factor speci¢c to the mam-
malian UPR [24,25]. ATF6 is synthesized as a 90
kDa type II transmembrane protein (p90ATF6) lo-
calized in the ER (Fig. 3). p90ATF6 is cleaved at or
close to the cytosolic face of the membrane in re-
sponse to ER stress. The N-terminal cytoplasmic do-
main (p50ATF6), which contains the bZIP domain,
is translocated into the nucleus and activates tran-
scription of ER molecular chaperone genes (Fig. 4).
Recently, ATF6 was demonstrated to be processed
by Site-1 protease (S1P) and Site-2 protease (S2P),
that are known to be processing enzymes as sterol
regulatory element binding proteins [26]. ATF6 pro-
cessing is blocked completely in cells lacking S2P and
partially in cells lacking S1P. Moreover, cells lacking
S2P failed to induce GRP78/BiP in response to ER
stress. These ¢ndings indicate that S1P and S2P are
required for the ER stress response as well as for
lipid synthesis, and also that cleavage of ATF6 at
the ER membrane is highly regulated by these pro-
teases during ER stress.
When newly synthesized proteins are disturbed in
their proper folding by ER stress, mRNA translation
is suppressed to synthesize proteins in addition to the
Fig. 3. Structures of ER stress transducers. IRE1K,L and PERK are type I transmembrane proteins, and the N-terminal domains of
both proteins are located in the ER lumen. ATF6 is a type II transmembrane with its N-terminal domain located in the cytoplasm,
and it is cleaved at or close to the cytosolic face of the ER membrane in response to ER stress (arrow). The luminal domain of each
protein contains potential N-linked glycosylation sites. TM, a putative transmembrane region; Linker, a region having no homology
to known proteins.
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transcriptional regulation of ER-resident molecular
chaperones. This phenomenon correlates with the in-
creased phosphorylation of the K subunit of eukary-
otic translation initiation factor 2 (eIF2K) [27]. Phos-
phorylated eIF2K interferes with the formation of an
active 43S translation initiation complex [28]. Re-
cently, PERK/PEK [29,30] was identi¢ed as an ER-
resident transmembrane protein kinase that phos-
phorylates eIF2K, and causes the reduction of pro-
tein synthesis rates (Fig. 3). Overexpression of PERK
inhibits the translation of both its own mRNA and
that of a reporter gene, and treatment with tunica-
mycin or thapsigargin increases autophosphorylation
of PERK [30], suggesting that PERK is oligomerized
and activated by its autophosphorylation during ER
stress (Fig. 4). The Perk gene has been targeted in
mouse embryonic stem cells, and Perk 3/3 cells
showed that the phosphorylation of eIF2K in re-
sponse to the accumulation of malfolded proteins
in the ER was abolished, and that they were more
sensitive to ER stress induced by treatment with tu-
nicamycin or thapsigargin than were wild type cells
Fig. 4. Mechanisms of ER stress response. A recent study proposed that activations of the signaling mediated ER stress transducers
could be triggered by dissociation of GRP78/BiP from stress transducers. The dissociation leads to oligomerization of stress trans-
ducers inducing their autophosphorylation (P) and the resultant activation of downstream signaling. Activation of PERK results in
phosphorylation of eIF2K, and leads to inhibition of translation initiation. Autophosphorylation and dimerization of IRE1s causes ac-
tivation of endonuclease domains that have the potential to cleave HAC1 mRNA, and generate an activated form of Hac1pi in yeast,
though a mammalian homologue of yeast HAC1 has not yet been identi¢ed. In addition, IRE1s also are implicated in JNK activa-
tion, by recruiting and clustering an adapter protein, TRAF2, at the ER membrane. ATF6 is cleaved at or close to the cytosolic face
of the membrane in response to ER stress. The N-terminal cytoplasmic domain (p50ATF6), which contains the DNA-binding, dimeri-
zation and transactivation domains, is translocated into the nucleus and activates transcription of ER molecular chaperone genes con-
taining the ER stress response element (ERSE), which is thought to be a regulatory element of the promoter regions conserved in ER
molecular chaperone genes in mammalian cells.
BBADIS 62037 30-5-01 Cyaan Magenta Geel Zwart
K. Imaizumi et al. / Biochimica et Biophysica Acta 1536 (2001) 85^96 89
[31]. The mechanisms of higher sensitivity to ER
stress in Perk 3/3 cells remain unclear, but are be-
lieved to be due to the enhanced accumulation of
misfolded proteins in the ER.
4. The mechanisms of stress sensing by transducers
The alignments of luminal domains in IRE1K,L
and PERK show signi¢cant homology, suggesting
that each stress transducer uses a similar mechanism
to sense the accumulation of misfolded proteins in
the ER lumen. Recently, it was demonstrated that
luminal domains of IRE1 and PERK are function-
ally interchangeable in mediating an ER stress re-
sponse [32,33]. Luminal domains of these molecules
form stable complexes with GRP78/BiP under non-
stress conditions. Perturbation of protein folding
promotes reversible dissociation of GRP78/BiP
from these luminal domains, and subsequently oligo-
merization of IRE1 and PERK occurs. Thus, activa-
tion of IRE1 and PERK is triggered by the dissoci-
ation of GRP78/BiP from these molecules. Although
the detailed mechanisms of dissociation of GRP78/
BiP from stress transducers are unknown, the
GRP78/BiP release could be caused by the accumu-
lation of misfolded proteins that compete with the
luminal domains of the stress signal transducers for
GRP78/BiP binding.
5. Apoptosis by ER stress
It has been reported that ER stress speci¢cally
activates the processing of the ER-resident proapop-
totic cysteine protease, caspase-12 [34,35]. Caspase-
12 is localized to the ER and activated by ER stress,
but not by plasma membrane- or mitochondrial-tar-
geted apoptotic signals. Procaspase-12 may be acti-
vated by direct proteolytic cleavage by a non-caspase
protease, calpain. Caspase-12 activation is a late
event in the response to the accumulation of mal-
folded proteins in the ER, and is presumed to be
triggered by insupportable levels of ER stress. The
cells derived from mice that are de¢cient in caspase-
12 are resistant to ER stress-induced apoptosis, but
undergo apoptosis in response to other death stimuli
including treatment with staurosporine or by trophic
factor deprivation. These ¢ndings indicate that cas-
pase-12 plays a key role in apoptosis induced by ER
stress. However, it is unknown whether activated
caspase-12 is implicated in cleaving procaspase-3,
and how caspase-3 is activated in cytoplasm after
activation of caspase-12 in the ER. Therefore, fur-
ther study is needed to understand how death signals
are transduced into the cytoplasm after ER stress.
In response to ER stress, the transcription factor
CHOP (C/EBP homologous protein-10, also known
as GADD153) is induced at the transcriptional level
[36^38]. CHOP is a nuclear protein that forms stable
heterodimers with C/EBP family members [39], and
the dimmers are capable of recognizing novel DNA
target sequences [40], suggesting that CHOP may
have a role in transducing signals from the stressed
ER to changes in gene expression. Overexpression of
CHOP can lead to the induction of growth arrest
and apoptosis [41,42]. CHOP-de¢cient mice have dis-
played reduced apoptosis in renal epithelium in re-
sponse to tunicamycin treatment [43]. Therefore,
CHOP has a crucial role in the induction of cell
death under conditions associated with malfunctions
of the ER.
ER stress leads to accumulation of malfolded pro-
teins in the ER lumen, and also activates c-JUN
NH2-terminal kinases (JNKs, also known as stress-
activated protein kinases (SAPKs)) [44,45]. Urano et
al. demonstrated that IRE1 activated JNK, and that
IRE1K 3/3 ¢broblasts were impaired in JNK acti-
vation by ER stress [46]. The cytoplasmic kinase do-
mains of IRE1s bind to TRAF2, an adapter protein
that couples plasma membrane receptors to JNK ac-
tivation, when IRE1s are activated by ER stress. At
present, it is unknown whether the pathway of
IRE1s-TRAF2-JNK plays roles in signaling for ap-
optosis or survival in response to ER stress.
6. Background of Alzheimer’s disease
Alzheimer’s disease (AD) is a progressive neurode-
generative disorder, characterized pathologically by
the deposition of amyloid-L protein (AL), formation
of neuro¢brillary tangles, and neuronal death in
brain lesions [47]. Some AD cases show FAD, indi-
cating genetic factors are involved in the pathogene-
sis. A subset of early-onset cases of FAD are caused
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by mutations in the amyloid precursor protein (APP)
gene which is located on chromosome 21 [48^50],
presenilin-1 (PS1) which is found on chromosome
14 [51], and presenilin-2 (PS2), located on chromo-
some 1 [52^54]. Mutations in the gene encoding PS1
are responsible for many cases of FAD. Although
the mechanisms by which mutations in PS1 predis-
pose individuals to FAD has not yet been deter-
mined, FAD-linked PS1 mutation is associated with
altered proteolytic processing of APP, such as an
increase in production of the highly amyloidogenic
AL peptide AL42 [55,56]. As AL production accom-
panied by the accumulation of carboxy-terminal
fragments of APP, which are generated by cleavage
of L- and Q-secretases for APP, was inhibited in PS1-
de¢cient cells [57], PS1 seems to be important in the
Q-secretase-mediated cleavage process involved in
generating AL.
7. Signaling pathway impairment of the unfolded
protein response by PS1 mutation
PS1 is a transmembrane protein localized mainly
to the ER. The molecule is subjected to endoproteo-
lytic cleavage near residue 290 within the loop do-
main [58,59], and the cleaved N- and C-terminal
fragments of approx. 35 and 20 kDa are located to
the Golgi apparatus. It is also known that mutations
in PS1 increase cellular susceptibility to apoptosis
induced by various insults, including the withdrawal
of trophic factors and exposure to AL [60,61]. In
Fig. 5. FAD-linked PS1 mutants and ER stress response. (A) Stable SK-N-SH cells expressing each PS1 construct were treated with
0.5 Wg/ml tunicamycin for 40 h. Neuronal death was determined by Live/Dead assay staining. Green cells are intact; red cells have
undergone apoptosis (arrowheads). Note that death of A246E-bearing cells was attenuated by infection with recombinant GRP78/BiP.
(B) The e¡ects of PS1 mutation on the expression of GRP78/BiP mRNA. SK-N-SH cells were exposed to 3 Wg/ml for 6 h. Total
RNA was isolated from each cell line, and subjected to Northern blotting with probes for GRP78/BiP mRNA (upper) or L-actin
mRNA (lower). Note that induction of GRP78/BiP mRNA in cells expressing PS1 mutants after treatment with tunicamycin was
attenuated. (C) Downregulated phosphorylation of IRE1K by PS1 mutants. 293T cells were co-transfected with IRE1K-Flag and each
PS1 construct. Cells were labeled with 32P for 2 h. (Upper panel) IRE1K-Flag (Ire1p) proteins were recovered by immunoprecipitation
with anti-Flag antibody and subjected to SDS^PAGE and autoradiography. (Lower panel) Western blotting con¢rmed that equivalent
amounts of IRE1K-Flag (Ire1p) were expressed in each cell line [62].
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order to clarify the molecular mechanisms of sensitiz-
ing to various cell stresses in cells expressing the PS1
mutation, it is important to understand the relation-
ship between ER function and the abilities of mutant
PS1 in apoptosis as PS1 is mainly localized to ER.
It has been demonstrated that the expression of
PS1 mutants linked to familial Alzheimer’s disease
in human neuroblastoma SK-N-SH cells increases
susceptibility to ER stress induced by tunicamycin
or calcium ionophore (Fig. 5A) [62,63]. This vulner-
ability to ER stress by mutant PS1 was caused by a
signi¢cant decrease in the amount of GRP78/BiP
mRNA induction (Fig. 5B). The same ¢ndings were
observed in primary neuronal cultures from PS1 mu-
tation (I213T) knock-in mice, indicating that the ef-
fects of mutant PS1 on ER stress were not arti¢cially
produced by overexpressing ER transmembrane pro-
teins such as mutant PS1. The vulnerability to ER
stress in FAD-liked PS1 mutant-expressing cells was
reversed by infection with recombinant GRP78/BiP
(Fig. 5A), suggesting that the reduction in GRP78/
BiP gene expression causes vulnerability to ER stress
in these cells. The decreased induction of GRP78/BiP
mRNA was attributed to the attenuation of activa-
tion of IRE1K, one of the ER stress transducers,
inhibiting its autophosphorylation (Fig. 5C). We
are currently examining whether mutant PS1 a¡ects
other ER stress transducers such as PERK and
ATF6. In SK-N-SH neuroblastoma stable trans-
formants of PS1 mutations (A246E, vE9) and PS1
mutation (I213T) knock-in ¢broblasts, autophos-
phorylation of PERK and cleavage of ATF6 at the
ER membrane and nuclear translocation of
p50ATF6 fragments were inhibited during ER stress
(T. Katayama and K. Imaizumi, unpublished obser-
vations), indicating that mutant PS1 perturbs func-
tions of each ER stress transducer and causes the
resultant downregulation of its downstream signal.
As described above, activations of IRE1s and
PERK are triggered by dissociation of GRP78/BiP
from these molecules; therefore, it is possible that
mutant PS1 could disturb the dissociation during
ER stress.
Recently, Niwa et al. reported that PS1-de¢cient
cells are reduced in their ability to mount a UPR,
with a reduction in nuclear accumulation of C-termi-
nal fragments of IRE1 [64]. They speculated that the
impairment of the UPR is based on a defect in the
UPR-induced proteolytic processing of IRE1 at its
intramembranous region by defects of Q-cleaving ac-
tivities associated with PS1. Ron and his colleagues
communicated that they observed no consistent de-
fects in either GRP78/BiP or CHOP induction or
activation of IRE1K in PS1 and PS2 double-knock-
out cells [65]. They were also not able to detect the
C-terminal IRE1 fragments by ER stress, but such
fragments might be short-lived and therefore di⁄cult
to detect [66]. The relationship between biological
functions of native PSs and ER stress response thus
needs to be explored further.
Sato et al. reported that FAD-linked PS1 muta-
tions have a discernable impact on the ER stress
response [67], a ¢nding that is not consistent with
the previous study. It is very important to show the
comparison between wild and mutant cells across
time, dose and cell types to convince colleagues of
an explanation for the discrepancies in the results
obtained by the two labs. The recent study demon-
strated that FAD-linked PS1 mutants delay the acti-
vation of stress transducers such as Ire1K and PERK
during ER stress [68]. However, the e¡ects of PS1
mutations could be masked by treatment with exces-
sive doses of ER stress inducers or by stimulation for
too long time. Thus, it is possible that one of their
inabilities to reproduce our results is due to their use
of time points that were too late (the activation of
Ire1K and PERK in their paper was observed at 5 h
after ER stress). The other possibility of their inabil-
ity may be attributed to their use of cells that are, in
comparison, not sensitive to ER stress (HEK293 and
Neuro2a cells).
8. ER stress and AL production
One of the most common pathological features in
AD brain is the deposition of AL. FAD-linked PS1
mutants alter the processing of APP and cause in-
creased production of the more amyloidogenic AL
peptide, AL42 [55,56]. The ER and ER^Golgi inter-
mediate compartment may be important sites for
generation of AL42 [69]. Interestingly, a mechanism
exists in cells by which unfolded proteins are re-
trieved to the ER by retrograde transport, and pre-
vented from moving to the cell surface [70]. These
facts raise the possibility that increased levels of
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AL42 in PS1 mutant-expressing cells might be the
result of the retention of unfolded APP in the ER
because of an impaired protein-folding system. Over-
expression of GRP78/BiP has been shown to reduce
amounts of AL40 and 42 secreted into the medium
[71], suggesting that the increased concentration of
GRP78/BiP in the ER lumen promotes a conforma-
tion of APP that hinders access of L-secretase. Alter-
natively, the IRE1 derivative, vIRE1, which has a
truncated cytoplasmic region and so lacks the kinase
and RNase L domains, causes elevation of secreted
AL40 and 42 under steady-state conditions [72]. Tak-
ing these ¢ndings into consideration, AL production
appears highly regulated by ER circumstances in-
cluding the protein-folding system for APP. How-
ever, the mechanism of which both AL40 and 42
are increased in cells bearing disturbed IRE1 is un-
clear as PS1 mutation only a¡ects the production of
AL42. Further analyses, using PERK or IRE1
knockout cells, are needed to clarify the relationship
of ER stress signaling and AL production, and to
examine the intracellular accumulation of AL under
ER stress conditions.
9. Conclusions and perspectives
It has been reported that some diseases such as
cystic ¢brosis, K1-antitrypsin de¢ciency, and retinitis
pigmentosa result from protein misfolding and accu-
mulation of those within the ER [1,2]. However, it is
not known how causative molecules in these diseases
a¡ect the ER stress response, and are involved in
disease onset. As shown in the present review, the
analyses of the activation of ER stress transducers
and the signaling pathways of its downstream could
make clear the target points for the causative mole-
cules in these diseases. Accumulation of abnormal
structures in cytoplasm or nucleus has been reported
to be implicated in neuronal degeneration in some
neuronal disorders such as Huntington’s [73] or
Parkinson’s disease [74]. The defects of protein-fold-
ing systems could be associated with production or
aggregation of causative molecules in these diseases.
Thus, modulation of ER stress signaling might
allow the development of therapeutic strategies
for some human diseases that are caused by ER dys-
function.
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